Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 16: 291-293, 1970;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bischoff, F.
Right arrow Articles by Bakhtiar, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bischoff, F.
Right arrow Articles by Bakhtiar, A. K.

Clinical Chemistry, Vol 16, 291-293, Copyright © 1970 by the American Association for Clinical Chemistry

Free-Electrophoretic Behavior of Urea-Insulin Reaction Products

Fritz Bischoff 1 and Abolfath Khan Bakhtiar 1

1 Chemical Laboratory, Santa Barbara Cottage Hospital Research Institute, Santa Barbara, Calif. 93105.

Five reaction products, previously isolated from an aqueous mixture of insulin and concentrated urea that had been subjected to various conditions of time and temperature, were examined by moving-boundary electrophoresis. Insulin OU and insulin IU separated into major and minor peaks with mobilities identical to those observed by Timasheff et al. (and confirmed by us) for intact crystalline insulin. Insulin IIU showed a major peak (80%) with a mobility of -7.6 x 10-5 cm/s/V/cm. Insulin IIIU showed a major peak with a mobility of -9.2 x 10-5 cm/s/V/cm. On the basis of change in electron charge and the fact that guanidine does not produce the effects of urea, it is postulated that the delayed-acting urea insulin (IIU) is formed by native insulin reacting with the isocyanate ion in urea solution.

Submitted on July 18, 1969
Accepted on August 29, 1969







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the American Association for Clinical Chemistry.